Evidence map›Paper›PMID 32500007›Full record

ArticleJournal of neurological surgery. Part B, Skull base2020

Longitudinal Radiographic Outcomes of Vestibular Schwannoma in Single and Fractionated Stereotactic Radiosurgery: A Retrospective Cohort Study.

Mohamed H Khattab, Neil B Newman, David M Wharton, Alexander D Sherry, Guozhen Luo, Nauman F Manzoor, Alejandro Rivas, L Taylor Davis, Lola B Chambless, Albert Attia and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurological surgery. Part B, Skull base, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Mohamed H KhattabDepartment of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Neil B NewmanDepartment of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
David M WhartonVanderbilt University School of Medicine, Nashville, Tennessee, United States.
Alexander D SherryVanderbilt University School of Medicine, Nashville, Tennessee, United States.ORCID 0000-0001-5115-1691
Guozhen LuoDepartment of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Nauman F ManzoorDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Alejandro RivasDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
L Taylor DavisDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Lola B ChamblessDepartment of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Albert AttiaDepartment of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Anthony J CmelakDepartment of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Vanderbilt University Medical Center · USVanderbilt University · USNeurological Surgery · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Management of vestibular schwannoma (VS) includes stereotactic radiosurgery (SRS) in single or fractionated treatments. There is a paucity of literature on the three-dimensional (3D) volumetric kinetics and radiological changes following SRS and no consensus on appropriate post-SRS surveillance imaging timeline. This is a retrospective cohort study with institutional review board approval. A total of 55 patients met study criteria. We collected volumetric kinetic data in VS treated with SRS over time using a target volume contouring software. We also tracked radiographic phenomena such as pseudoprogression and necrosis. A secondary objective was to describe our overall treatment success rate and any failures. For all treatments groups, pseudoprogression most typically occurred within 12 months post-SRS, after which tumor volumes on average normalized and then decreased from pretreatment size at the last follow-up. Only two patients required salvage therapy post-SRS and were considered SRS treatment failures. Both patients were in the five-fraction cohort but with a lower biologically equivalent dose. Our study is first to collect 3D volumetric kinetics of VS following single and fractionated SRS in contrast to extrapolations from single and two-dimensional measurements. Our longitudinal data also show initial increases in volume in the first 12 months post-SRS followed by later declines, setting up interesting questions regarding the utility of early posttreatment surveillance imaging in the asymptomatic patient. Finally, we show low rates of treatment failure (3.6%) and show in our cohort that SRS dose de-escalation posed a risk of treatment failure.

Indexed as

fractionationpseudoprogressionstereotactic radiosurgeryvestibular schwannomavolumetric

Identifiers

PMID32500007
PMCPMC7253303
OpenAlexW2950235508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.